Parkinson’s disease is set to rise dramatically, with cases expected to more than double by 2050, largely due to an aging ...

People with Parkinson's disease who have a pacemaker-like device implanted in the brain spend an extra four-plus hours a day free of tremors and involuntary movements than they do on medication, ...

Case marks the beginning of a multi-site pivotal trial to evaluate Abbott’s system for management of treatment-resistant ...

Researchers from Carnegie Mellon University and Allegheny Health Network have developed a new method for deep brain stimulation. The technique, called “ DeepFocus ,” uses transnasal electrical ...

Researchers studying brain waves have suggested that a new discovery they have made could hold the key to treating anxiety in people diagnosed with P ...

Noida: A native of Kazakhstan, who had been experiencing locomotor disability for the last 14 years, as a side effect of ...

For the one million people diagnosed with Parkinson's disease in the United States, Medtronic plc (NYSE:MDT), a global leader in healthcare technology, proudly announces U.S. Food and Drug ...

Medtronic gets US FDA nod for the world’s first adaptive deep brain stimulation system for people with Parkinson’s disease: Galway, Ireland Saturday, March 1, 2025, 09:00 Hrs ...

There is no cure for Parkinson's, and over one million people have the disease in the United States alone. However, deep brain stimulation (DBS) has been used to treat this and other neurological ...

The FDA approves BrainSense Adaptive deep brain stimulation and electrode identifier technology for the treatment of ...

In this week’s edition of InnovationRx, we look at Eli Lilly’s weight-loss pill stockpiling, scaling stem cell manufacturing, the growing measles outbreak in Texas, ...

The FDA has approved Medtronic's Brainsense Adaptive deep brain stimulation for patients with Parkinson's disease. The technology is designed to adjust therapy in real time based on a patient's brain ...